L-methylfolate is used for dietary management of low blood cell folate level in certain patients. Folic Acid is proven to reduce the risk of neural tube defects (NTDs) and birth defects such as spina bifida and anencephaly by as much as 70 percent if taken at least 1 month before pregnancy. Many people are unable to fully convert regular folic acid to L-methylfolate. This limited absorption results in a significant reduction in the amount of L-methylfolate made available to the body limiting the ability to build and maintain healthy reserves of folic acid and significantly increases the risk of birth defects. L-methylfolate and methylcobalamin is also proven to lower levels of homocysteine - an amino acid linked to cardiovascular disease and more importantly, pregnancy complications. Such pregnancy complications include: preeclampsia, low birth weight, miscarriage, recurrent pregnancy loss and placental abruption. DHA is a vital ingredient in brain and retinal tissue, so it's essential for proper brain growth and eye development in fetus and young babies. Pre-eclampsia and neonatal hypocalcaemia are the most prevalent complications of maternal hypocalcaemia and are clearly associated with substantial morbidity. Maternal vitamin D is important to fetal bone development. Fetal lung development and neonatal immune conditions such as asthma may relate in part to maternal vitamin D levels.